company background image
ASTH logo

Astrana Health Informe acción NasdaqCM:ASTH

Último precio

US$42.86

Capitalización de mercado

US$2.1b

7D

1.8%

1Y

23.2%

Actualizada

29 Nov, 2024

Datos

Finanzas de la empresa +

Astrana Health, Inc.

Informe acción NasdaqCM:ASTH

Capitalización de mercado: US$2.1b

Resumen de acción ASTH

Astrana Health, Inc. es una empresa de gestión sanitaria basada en tecnología centrada en el médico que presta servicios de atención médica en Estados Unidos. Saber más

Análisis fundamental de ASTH
Puntuación del snowflake
Valoración1/6
Crecimiento futuro5/6
Rendimiento pasado5/6
Salud financiera4/6
Dividendos0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Competidores de Astrana Health, Inc.

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Astrana Health
Precios históricos de las acciones
Precio actual de la acciónUS$42.86
Máximo en las últimas 52 semanasUS$63.20
Mínimo de 52 semanasUS$32.32
Beta1.24
1Cambio en 1 mes-22.93%
Variación en 3 meses-10.32%
Cambio de 1 año23.16%
3Variación en 3 años-43.25%
Variación en 5 años125.46%
Variación desde la OPV295.39%

Noticias y actualizaciones recientes

Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Nov 22
Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Nov 18
Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Recent updates

Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Nov 22
Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Nov 18
Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Nov 10
Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Oct 04
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Sep 12
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Aug 28
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27
With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Nov 08
Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Oct 26
Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Sep 22
Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Aug 04
Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Jul 19
A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Jun 19
We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 05
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20
Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06
Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Rentabilidad de los accionistas

ASTHUS HealthcareMercado US
7D1.8%2.0%1.6%
1Y23.2%7.5%32.3%

Rentabilidad vs. Industria: ASTH superó a la industria US Healthcare, que obtuvo un rendimiento del 7.5% el año pasado.

Rentabilidad vs. Mercado: ASTH obtuvo unos resultados inferiores a los del mercado US, que fueron del 32.3% el año pasado.

Volatilidad de los precios

Is ASTH's price volatile compared to industry and market?
ASTH volatility
ASTH Average Weekly Movement8.0%
Healthcare Industry Average Movement7.0%
Market Average Movement6.3%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: ASTH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de ASTH (8%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19851,800Brandon Simwww.astranahealth.com

Astrana Health, Inc. es una empresa de gestión sanitaria basada en tecnología centrada en el médico que presta servicios de atención médica en Estados Unidos. Opera a través de tres segmentos: Care Partners, Care Delivery y Care Enablement. La empresa aprovecha su plataforma patentada de gestión de la salud de la población y prestación de asistencia sanitaria, opera un modelo de asistencia sanitaria integrado y basado en el valor que capacita a los proveedores de su red para prestar asistencia a sus pacientes.

Resumen de fundamentos de Astrana Health, Inc.

¿Cómo se comparan los beneficios e ingresos de Astrana Health con su capitalización de mercado?
Estadísticas fundamentales de ASTH
Capitalización bursátilUS$2.11b
Beneficios(TTM)US$62.46m
Ingresos (TTM)US$1.72b

33.7x

Ratio precio-beneficio (PE)

1.2x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de ASTH
IngresosUS$1.72b
Coste de los ingresosUS$1.46b
Beneficio brutoUS$259.89m
Otros gastosUS$197.43m
BeneficiosUS$62.46m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)1.27
Margen bruto15.09%
Margen de beneficio neto3.63%
Ratio deuda/patrimonio86.4%

¿Cómo se ha desempeñado ASTH a largo plazo?

Ver rendimiento histórico y comparativa